current
licens
eggderiv
influenza
vaccin
efficaci
protect
percent
vaccin
recipi
recent
threat
pandem
influenza
outbreak
anticip
increas
demand
season
influenza
vaccin
owe
expand
vaccin
recommend
requir
evalu
altern
nonegg
base
technolog
manufactur
influenza
vaccin
product
eggderiv
vaccin
easili
scalabl
limit
avail
chicken
egg
eggbas
influenza
vaccin
manufactur
process
labor
intens
requir
long
term
plan
long
annual
product
cycl
difficulti
product
scaleup
potenti
exposur
chicken
flock
avian
influenza
virus
prompt
evalu
cell
cultur
vaccin
product
platform
altern
egg
depend
product
medimmun
current
manufactur
live
attenu
viru
laiv
vaccin
indic
activ
immun
individu
year
age
influenza
diseas
caus
influenza
viru
subtyp
b
part
medimmun
effort
develop
laiv
use
cell
cultur
product
technolog
investig
biolog
clone
madindarbi
canin
kidney
mdck
cell
line
produc
high
titer
influenza
viru
substrat
product
evalu
impact
produc
laiv
high
yield
clone
mdck
cell
assess
vitro
suscept
viru
replic
kinet
influenza
viru
produc
cell
use
specificpathogen
free
spf
egg
addit
medimmun
clone
mdck
cell
use
two
human
cell
line
evalu
compar
infect
replic
assess
whether
product
system
impact
human
cell
line
use
evalu
human
lung
carcinoma
cell
human
mucoepidermoid
bronchiolar
carcinoma
nci
cell
cell
previous
shown
differ
suscept
influenza
virus
cell
use
studi
support
product
viral
replic
level
kinet
similar
human
primari
lung
cell
nci
cell
previous
shown
good
isol
replic
mani
human
virus
includ
vaccinia
viru
hsv
adenoviru
polyoma
bk
viru
paramyxovirus
nci
cell
also
suggest
altern
primari
rhesu
monkey
kidney
cell
isol
replic
human
paramyxovirus
virus
replic
nci
cell
includ
cmv
vzv
respiratori
coronavirus
influenza
type
b
virus
addit
nci
cell
studi
evalu
influenza
viru
replic
proinflammatori
cytokin
respons
influenza
viru
induc
apoptosi
virus
use
studi
viru
strain
compon
northern
hemispher
influenza
season
trival
vaccin
ca
anew
ca
ca
strain
produc
mdck
cultur
well
egg
vaccin
strain
use
infect
mdck
nci
cell
line
specif
moi
cell
cultur
supernat
cell
lysat
formalinfix
cell
monolay
collect
h
postinfect
respect
test
sampl
analyz
fluoresc
focu
assay
ffa
realtim
qrtpcr
immunofluoresc
western
blot
analysi
hemagglutin
assay
ha
report
evalu
influenza
viru
produc
high
yield
mdck
cell
clone
compar
viru
produc
spf
chicken
egg
high
yield
mdck
cell
permiss
egg
produc
ep
cell
produc
cp
attenu
vaccin
strain
nci
cell
less
permiss
influenza
strain
compar
mdck
cell
regardless
product
system
base
studi
result
conclud
clone
mdck
cell
produc
egg
produc
influenza
vaccin
strain
highli
compar
three
season
vaccin
compon
produc
use
egg
mdck
cell
product
platform
test
viru
use
repres
egg
cell
produc
influenza
b
viru
repres
anew
viru
respect
three
season
strain
produc
classic
reassort
process
accord
current
licens
laiv
master
viru
seed
mv
process
cell
produc
viru
studi
gener
viru
seed
use
manufactur
eggderiv
virus
briefli
egg
produc
viru
strain
produc
spf
egg
inocul
ml
log
tcid
ml
inocul
egg
incub
presenc
humid
h
viru
h
influenza
b
viru
viru
contain
allanto
fluid
harvest
stabil
sucros
phosphat
buffer
process
downstream
purif
final
purifi
bulk
test
viru
concentr
store
c
use
egg
produc
virus
subject
four
passag
egg
mv
manufactur
process
mdck
cell
produc
virus
propag
mdck
cell
use
suffici
quantiti
cell
bioreactor
inocul
cell
allow
attach
microcarri
control
ph
presenc
co
viral
infect
mdck
cell
cultur
achiev
allow
microcarri
settl
addit
infect
medium
appropri
volum
master
viru
seed
stock
upon
addit
infect
medium
viru
inoculum
cell
cultur
maintain
c
h
end
infect
cell
cultur
supernat
collect
process
downstream
purif
final
purifi
bulk
test
viru
concentr
store
c
use
human
lung
carcinoma
cell
atcccatalogu
lot
cultur
ham
media
supplement
fetal
bovin
serum
fb
c
presenc
co
human
mucoepidermoid
pulmonari
carcinoma
nci
cell
atcccatalogu
lot
propag
rpmi
medium
supplement
fb
mdck
clone
cell
proprietari
cell
line
develop
medimmun
first
grown
roller
bottl
seed
tissu
cultur
plate
prior
infect
nci
cell
expand
tissu
cultur
flask
prior
infect
well
plate
cell
seed
well
plate
seed
densiti
cellswel
ml
complet
growth
media
cell
incub
h
c
co
confluent
well
plate
confluent
well
wash
ml
hank
balanc
salt
solut
hbss
prior
infect
base
cell
count
per
well
viru
titer
egg
produc
ep
cell
produc
cp
virus
dilut
complet
growth
medium
use
infect
cell
moi
except
also
infect
moi
well
plate
inocul
ml
inoculum
incub
c
co
min
follow
viru
adsorpt
cell
monolay
wash
hbss
well
replac
ml
complet
growth
media
cell
cultur
supernat
cell
lysat
collect
h
postinfect
pi
store
c
test
test
sampl
includ
clarifi
stabil
cell
cultur
supernat
cell
lysat
rna
extract
western
blot
analysi
formalinfix
cell
monolay
ffa
antibodi
bind
stain
method
use
potenc
determin
influenza
viru
titer
cell
supernat
collect
h
pi
appropri
dilut
viru
growth
medium
case
sampl
low
viru
concentr
dilut
scheme
alter
briefli
atcc
madindarbi
canin
kidney
mdck
cell
tissu
cultur
plate
infect
inocul
l
appropri
viru
dilut
incub
plate
c
presenc
co
h
polyclon
chicken
antisera
viru
use
primari
antibodi
rabbit
antichicken
igg
conjug
fitc
use
secondari
antibodi
use
detect
infect
cell
prior
titer
determin
total
rna
isol
cell
line
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
minor
modif
briefli
l
rlt
buffer
ad
well
allow
incub
room
temperatur
min
cell
scrape
total
rna
extract
rneasi
spin
column
purifi
rna
elut
l
nucleasefre
water
store
c
use
uninfect
total
cell
rna
also
extract
use
control
rna
isol
sucros
phosphat
buffer
stabil
cell
supernat
use
rneasi
kit
qiagen
accord
manufactur
spin
technolog
instruct
minor
modif
rna
extract
rneasi
spin
column
plate
purifi
rna
elut
l
nucleasefre
water
store
c
use
realtim
onestep
rtpcr
reaction
carri
use
abi
taqman
onestep
rtpcr
master
mix
accord
manufactur
instruct
total
volum
l
templat
control
ntc
reaction
contain
l
nucleasefre
water
sampl
test
duplic
dilut
seri
purifi
influenza
b
rna
known
viru
titer
log
ffuml
perform
l
standard
dilut
run
triplic
construct
standard
curv
thermal
cycl
perform
fast
realtim
pcr
system
abi
rt
step
involv
incub
c
min
pcr
cycl
condit
includ
c
min
cycl
c
c
min
quantiti
copi
number
test
sampl
calcul
base
standard
curv
report
rtpcr
log
copiesml
revers
transcript
rna
random
hexam
perform
final
volum
l
unit
rnase
inhibitor
l
sampl
standard
rna
use
high
capac
cdna
revers
transcript
kit
abi
multiplex
realtim
pcr
reaction
carri
use
taqman
univers
pcr
master
mix
accord
manufactur
instruct
total
volum
l
primer
probe
np
segment
influenza
influenza
b
obtain
abi
reaction
custom
primer
probe
use
final
concentr
nm
nm
respect
along
final
concentr
eukaryot
rrna
taqman
endogen
control
vic
mgb
abi
sampl
test
triplic
thermal
cycl
perform
fast
realtim
pcr
system
abi
standard
mode
pcr
cycl
condit
includ
ung
incub
c
min
denatur
c
min
follow
cycl
c
c
min
quantiti
copi
number
test
sampl
calcul
report
log
copiesml
follow
harvest
supernat
time
point
cell
tc
plate
wash
pb
fix
formalin
min
c
plate
wash
twice
mlwell
pb
sheep
antianew
crossreact
use
primari
antibodi
dilut
primari
antibodi
treat
plate
incub
c
h
wash
ml
tpb
pb
min
interv
wash
dilut
fitcconjug
secondari
antibodi
ad
plate
incub
c
h
wash
mlwell
tpb
wash
fluid
remov
plate
airdri
room
temperatur
plate
screen
fluoresc
use
fluoresc
microscop
imag
captur
analysi
protein
viru
infect
cell
lysat
separ
electrophoresi
use
biorad
precast
gel
denatur
reduc
condit
tenwel
sdspolyacrylamid
gel
use
size
separ
protein
sampl
sampl
denatur
use
sampl
buffer
heat
c
min
sampl
normal
protein
concentr
biorad
kaleidoscop
rainbow
marker
amersham
bioscienc
molecular
weight
marker
use
gel
electrophoresi
perform
run
buffer
v
h
follow
electrophoresi
sizesepar
protein
transfer
precut
pvdf
membran
biorad
blot
modul
use
transfer
buffer
protein
transfer
h
v
ice
bath
pvdf
membran
transfer
protein
block
overnight
solut
nonfat
dri
milk
solut
contain
block
pvdf
membran
wash
wash
buffer
react
h
rocker
plate
room
temperatur
appropri
dilut
sheep
antisera
anew
respect
wash
pvdf
membran
react
goat
antisheep
igghrp
conjug
h
rocker
plate
room
temperatur
viral
protein
detect
use
pierc
supersign
west
pico
chemiluminesc
substrat
film
hemagglutin
ha
assay
perform
use
freshli
prepar
chicken
turkey
guinea
pig
rbc
prepar
pb
cultur
supernat
harvest
h
postinfect
test
hemagglutin
activ
briefli
l
undilut
cell
supernat
ad
first
well
vbottom
plate
contain
lwell
dpb
serial
twofold
dilut
perform
l
appropri
red
blood
cell
suspens
ad
well
plate
incub
undisturb
room
temperatur
rt
min
ha
result
record
result
report
log
ha
unit
rna
supernat
viru
infect
well
extract
use
qiaamp
viral
rna
mini
kit
qiagen
per
manufactur
instruct
l
use
gener
ha
na
rtpcr
product
sequenc
follow
rtpcr
amplif
singletub
microspin
spin
column
use
clean
amplicon
analysi
pcr
product
concentr
determin
agaros
gel
electrophoresi
sequenc
perform
use
prism
bigdy
termin
cycl
sequenc
readi
reaction
kit
abi
use
standard
cycl
sequenc
condit
unincorpor
dye
termin
remov
use
performa
tm
dtr
gel
filtrat
block
purifi
product
collect
microamp
pcr
plate
electrophoresi
sequenc
perform
use
dna
analyz
abi
data
file
process
use
sequench
tm
softwar
fluoresc
focu
assay
ffa
perform
quantit
infecti
viru
compar
replic
kinet
ep
cp
influenza
virus
mdck
nci
cell
viru
titer
measur
use
ffa
found
compar
ep
cp
influenza
virus
indic
cell
mdck
cell
infect
moi
differ
log
ffuml
viru
peak
titer
observ
ep
cp
anew
viru
fig
result
replic
kinet
suggest
mdck
cell
highli
permiss
cp
ep
influenza
b
virus
peak
viru
titer
ep
cp
influenza
b
viru
determin
respect
nci
cell
viru
titer
limit
detect
ffa
log
ffuml
infect
either
ep
cp
anew
moi
detect
viru
titer
ep
cp
viru
infect
nci
cell
observ
infect
moi
howev
peak
viru
titer
log
ffuml
suggest
restrict
permiss
nci
cell
influenza
viru
infect
use
studi
protocol
data
shown
result
demonstr
medimmun
clone
mdck
cell
highli
permiss
influenza
viru
infect
irrespect
product
platform
gener
high
titer
ca
attenu
influenza
virus
evalu
effect
product
substrat
replic
kinet
influenza
virus
total
viral
rna
log
copiesml
measur
ep
cp
infect
mdck
nci
cell
cultur
supernat
use
qrtpcr
comparison
ep
cp
viru
replic
kinet
show
capabl
effici
replic
mdck
cell
peak
viral
rna
copi
number
ep
cp
anew
mdck
cell
supernat
determin
respect
similar
mdck
cell
replic
ep
cp
influenza
virus
nci
cell
found
compar
cell
infect
moi
egg
cp
anew
viru
peak
viral
copi
number
determin
respect
ep
cp
viru
replic
poorli
cell
nci
cell
viru
replic
sever
restrict
viral
rna
detect
cultur
supernat
ep
cp
virus
similar
replic
cell
replic
restrict
nci
cell
ep
cp
virus
fig
replic
kinet
measur
use
viral
rna
copi
like
ffa
assay
confirm
viru
product
platform
minim
impact
replic
coldadapt
influenza
virus
result
also
suggest
clone
mdck
cell
highli
permiss
ep
cp
influenza
virus
effici
intracellular
viral
replic
also
evalu
measur
np
segment
rna
express
kinet
use
viral
rna
accumul
infect
whole
cell
lysat
compar
accumul
np
viral
rna
infect
mdck
higher
three
virus
compar
nci
cell
confirm
highli
permiss
natur
mdck
cell
influenza
viru
infect
fig
result
demonstr
intracellular
influenza
segment
rna
express
effici
mdck
cell
compar
restrict
replic
kinet
nci
cell
level
np
segment
rna
mdck
cell
lysat
found
similar
ep
cp
influenza
virus
result
confirm
minim
impact
egg
cell
product
platform
intracellular
viral
express
kinet
assess
impact
product
platform
influenza
viru
protein
express
western
blot
perform
cell
lysat
cp
ep
infect
mdck
nci
cell
mdck
cell
infect
anew
viru
protein
express
detect
western
blot
show
three
major
protein
band
correspond
earli
h
postinfect
fig
profil
ha
protein
express
similar
ep
cp
b
influenza
viru
respect
similarli
viral
protein
also
detect
cell
infect
anew
viru
nci
cell
infect
egg
cellbas
viru
data
shown
viral
protein
express
ep
cp
virus
found
compar
confirm
minim
impact
product
platform
viru
replic
assess
effect
product
platform
viru
receptor
bind
properti
hemagglutin
activ
cell
cultur
supernat
cp
ep
viru
infect
mdck
nci
cell
measur
ha
titer
use
chicken
turkey
guinea
pig
red
blood
cell
ep
cp
influenza
virus
infect
mdck
nci
cell
found
compar
compar
wildtyp
ha
sequenc
hemagglutinationinhibit
hai
analysi
previou
studi
compar
viru
without
substitut
reveal
differ
virus
broad
rang
cell
substrat
avail
develop
human
biolog
howev
includ
vero
cef
cho
cell
earn
accept
among
regulatori
agenc
differ
cell
substrat
manufactur
biolog
consid
develop
new
biolog
especi
true
case
pandem
season
inactiv
influenza
vaccin
cell
substrat
evalu
use
includ
vero
suspens
adher
mdck
tabl
comparison
hemagglutin
activ
cell
egg
produc
influenza
b
viru
infect
cell
insect
cell
transgen
plant
also
shown
use
gener
subunit
influenza
vaccin
new
substrat
use
vaccin
develop
also
rais
concern
safeti
assess
safeti
risk
use
novel
substrat
take
account
advanc
made
manufactur
process
purif
technolog
methodolog
evalu
risk
high
yield
mdck
clone
use
medimmun
well
character
shown
safe
manufactur
laiv
data
discuss
clone
mdck
cell
line
develop
atcc
cell
line
bank
establish
later
adapt
grow
serumfre
growth
medium
briefli
high
yield
mdck
cell
initi
clone
serum
contain
medium
screen
viru
product
clone
later
adapt
grow
serumfre
condit
gener
access
master
cell
bank
clone
mdck
cell
well
character
shown
free
adventiti
agent
demonstr
nontumorigen
anim
model
egg
cell
produc
influenza
virus
show
remark
similar
abil
infect
clone
mdck
nci
cell
clone
mdck
cell
highli
permiss
infect
three
egg
cell
produc
influenza
viru
nci
cell
comparison
clone
mdck
cell
permiss
anew
viru
allow
limit
restrict
replic
viru
repres
egg
cell
product
process
base
vitro
substrat
suscept
infect
progress
receptor
bind
abil
replic
kinet
viral
rna
protein
express
ha
na
sequenc
comparison
coldadapt
influenza
viru
gener
use
clone
mdck
cellbas
product
technolog
found
similar
laiv
gener
use
egg
base
manufactur
process
